- Home
- LXRX vs CBAN Comparison
LXRX vs CBAN Comparison
Compare LXRX & CBAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LXRX | CBAN |
|---|---|---|
| Founded | 1995 | 1975 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 465.2M | 396.8M |
| IPO Year | 2000 | 1998 |
Fundamental Metrics
Financial Performance| Metric | LXRX | CBAN |
|---|---|---|
| Price | $1.31 | $20.32 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $3.23 | N/A |
| AVG Volume (30 Days) | ★ 4.1M | 108.0K |
| Earning Date | 03-05-2026 | 01-28-2026 |
| Dividend Yield | N/A | ★ 2.33% |
| EPS Growth | N/A | ★ 16.83 |
| EPS | N/A | ★ 1.59 |
| Revenue | $70,864,000.00 | ★ $127,681,000.00 |
| Revenue This Year | $56.61 | $33.81 |
| Revenue Next Year | N/A | $5.43 |
| P/E Ratio | ★ N/A | $12.95 |
| Revenue Growth | ★ 1255.21 | 13.59 |
| 52 Week Low | $0.28 | $13.99 |
| 52 Week High | $1.83 | $21.46 |
Technical Indicators
Market Signals| Indicator | LXRX | CBAN |
|---|---|---|
| Relative Strength Index (RSI) | 49.20 | 62.81 |
| Support Level | $1.17 | $18.32 |
| Resistance Level | $1.39 | $21.38 |
| Average True Range (ATR) | 0.14 | 0.59 |
| MACD | -0.01 | 0.04 |
| Stochastic Oscillator | 33.61 | 64.65 |
Price Performance
Historical ComparisonAbout LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
About CBAN Colony Bankcorp Inc.
Colony Bankcorp Inc is a bank holding company. The bank provides a broad range of banking services to its retail and commercial customers. Its product line includes loans to small and medium-sized businesses, residential and commercial construction and land development loans, commercial real estate loans, agri-business and production loans, residential mortgage loans, consumer loans, and a variety of demand, savings, and time deposit products. The company's segments include the Banking Division, Retail Mortgage Division and small business specialty lending divisions. It generates maximum revenue from the Banking Division.